CELS Showcase Investor / Executive RSVP
You are cordially invited for the Canada in the Valley, Life Sciences Showcase, a highly curated one-day gathering connecting vetted Canadian life science companies with U.S. investors, strategics, and experienced operators.
The Showcase is designed for investors who want efficient exposure to credible cross-border opportunities, without the noise of a large conference.
You are welcome to participate in any combination of the following:
8:30 am - 12:30 pm - Speaker sessions featuring industry leaders and experienced operators discussing commercialization, capital strategy, and U.S. market entry
12:30 pm - 1:30 pm - Executive lunch roundtable, small-group, off-the-record discussions with fellow investors and senior leaders
2:00 pm - 4:30 pm - Curated 1:1 investor and mentor meetings with select CELS portfolio companies aligned to your interests
5:00 pm - 7:30 pm - Evening networking receptions with investors, founders, executives, and ecosystem partners
CELS has supported more than 100 Valley Ready alumni companies, several of which have successfully raised capital and secured U.S. partnerships following participation in our programs.
If this aligns with your strategic interests, we would be pleased to have you join us. You'll select companies you are interested in meeting during the confirmation process.
Participating Companies
1. Kare Chemical Technologies: Kare has a patented catalytic process to synthesize a diverse library of CB1 and CB2 ligands for CNS targets such as epilepsy, chronic pain and metabolism
2. Qualisure: Qualisure Diagnostics is building a software-defined molecular diagnostics infrastructure that transforms RNA sequencing data into clinically actionable insights, enabling decentralized, globally scalable precision oncology.
3. Integrated Nanotherapeutics (INT): Multi-cargo LNP platform (mRNA + small molecule) for antigen-specific immune tolerance.
4. Rewire Digital Health: They build mobile games that diagnose, monitor and treat PDD.
5. Stereo Biotherapeutics: Stereo Biotherapeutics is developing multi-specific T-cell engagers to tackle two of the main challenges of solid tumor treatment: target specificity and tumor heterogeneity.
6. Bright Angel Therapeutics: Bright Angel Therapeutics is developing next-generation antifungals using dual-target conjugate molecules to overcome resistance in life-threatening infections.
7. NeuroServo: A medical device company developing an AI-assisted EEG platform for rapid neurological assessment at the point of care.
8. Synakis: Synakis has developed a patented, injectable hydrogel that mimics the native vitreous-transparent, non-swelling, biodegradable, and formed under mild, biocompatible conditions for ocular delivery.
9. Celestra Health Systems: Celestra Health Systems is a world-leader in the measurement of neurological gait, with a singular focus on neurodegenerative diseases such as Parkinson's disease and Multiple Sclerosis (MS).
10. pHarm Therapeutics Inc. : pHarmTx is developing next generation therapeutics for the management of acute and chronic pain.